MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.
Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.
Disposable Venous Blood Collection Needle by Type (20G (0.9×28mm), 21G (0.8×27mm), 22G (0.7×25mm), 23G (0.6×22mm), 24G (0.55×19mm)), by Application (Hospital, Clinic), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast 2026-2034
The global Disposable Venous Blood Collection Needle market is experiencing robust growth, projected to reach approximately USD 245.1 million in 2025, with a significant Compound Annual Growth Rate (CAGR) of 15.0% through 2033. This expansion is primarily fueled by the increasing prevalence of chronic diseases, a growing emphasis on routine diagnostic testing, and the rising demand for minimally invasive procedures in healthcare settings. The convenience, sterility, and single-use nature of these needles significantly reduce the risk of cross-contamination and healthcare-associated infections, making them indispensable in hospitals and clinics worldwide. Advancements in needle technology, such as the development of sharper and thinner gauges, are further contributing to patient comfort and procedural efficiency, thereby driving market adoption. The ongoing expansion of healthcare infrastructure, particularly in emerging economies, and increased patient awareness regarding early disease detection are also key growth catalysts.
Disposable Venous Blood Collection Needle Market Size (In Million)
750.0M
600.0M
450.0M
300.0M
150.0M
0
245.1 M
2025
281.9 M
2026
324.1 M
2027
372.8 M
2028
428.7 M
2029
492.8 M
2030
566.2 M
2031
The market segmentation by type highlights the dominance of specific gauges catering to diverse clinical needs, with 20G, 21G, and 22G needles likely representing the largest shares due to their widespread application in general phlebotomy. Hospitals and clinics form the cornerstone of the application segment, owing to the high volume of blood collection procedures conducted in these environments. Geographically, North America and Europe are expected to maintain a strong market presence due to advanced healthcare systems and high diagnostic testing rates. However, the Asia Pacific region, driven by countries like China and India, is poised for substantial growth owing to a large patient population, increasing healthcare expenditure, and a growing adoption of modern medical practices. The competitive landscape is characterized by a mix of established global players and emerging regional manufacturers, all striving for market share through product innovation, strategic collaborations, and expanding distribution networks to cater to the ever-increasing global demand for safe and efficient blood collection solutions.
Disposable Venous Blood Collection Needle Company Market Share
Loading chart...
Disposable Venous Blood Collection Needle Trends
The global market for disposable venous blood collection needles is poised for substantial growth, driven by an increasing demand for minimally invasive diagnostic procedures and a rising global healthcare expenditure. XXX projects that the market will witness a Compound Annual Growth Rate (CAGR) of approximately 5.5% during the forecast period of 2025-2033, reaching a valuation of over \$2,500 million by 2033. This upward trajectory is underpinned by several key trends. Firstly, the aging global population is a significant demographic factor, leading to a higher incidence of chronic diseases that necessitate regular blood testing. This, in turn, fuels the demand for safe and efficient blood collection devices. Secondly, advancements in needle technology, focusing on improved patient comfort and reduced risk of needlestick injuries, are contributing to market expansion. The development of thinner gauge needles, advanced coatings for reduced friction, and ergonomic designs are all factors influencing adoption. Furthermore, the growing awareness and implementation of stringent infection control protocols across healthcare settings globally are mandating the use of sterile, single-use blood collection devices, thereby boosting the disposable segment. The increasing prevalence of point-of-care testing (POCT) and home healthcare services is also creating new avenues for market growth, as these settings increasingly rely on convenient and disposable blood collection solutions. The market is also characterized by a growing emphasis on product innovation, with manufacturers investing in research and development to create needles with enhanced safety features, such as retractable safety mechanisms and integrated blood collection tubes. The digitalization of healthcare records and the integration of laboratory information systems (LIS) also indirectly support the demand for standardized and reliable blood collection tools. Finally, the expanding healthcare infrastructure in emerging economies is opening up new market opportunities, as these regions witness an increased focus on improving diagnostic capabilities and patient care.
Driving Forces: What's Propelling the Disposable Venous Blood Collection Needle
The disposable venous blood collection needle market is experiencing robust growth fueled by a confluence of powerful drivers. Foremost among these is the escalating global burden of chronic diseases. Conditions like diabetes, cardiovascular diseases, and various forms of cancer necessitate frequent blood monitoring and diagnostic testing, directly translating into a sustained and growing demand for venipuncture devices. This trend is further amplified by the aging global demographic, as older populations generally exhibit a higher prevalence of such chronic ailments requiring ongoing medical attention. Alongside this, the increasing healthcare expenditure across both developed and developing nations plays a pivotal role. As governments and private entities invest more in healthcare infrastructure and accessibility, the utilization of essential medical supplies, including blood collection needles, naturally rises. Furthermore, a paramount driver is the unwavering emphasis on patient safety and infection control. Healthcare institutions worldwide are implementing stringent protocols to minimize the risk of healthcare-associated infections and accidental needlestick injuries. Disposable needles, being sterile and single-use, are instrumental in achieving these safety objectives, making them the preferred choice over reusable alternatives, which pose significant sterilization challenges and infection risks. The continuous evolution and adoption of advanced medical technologies also contribute significantly. Innovations in needle design, such as thinner gauges, lubricated surfaces, and safety mechanisms, enhance patient comfort and reduce the likelihood of complications, thereby driving market adoption.
Challenges and Restraints in Disposable Venous Blood Collection Needle
Despite the promising growth trajectory, the disposable venous blood collection needle market is not without its challenges and restraints. A significant hurdle is the price sensitivity prevalent in certain markets, particularly in developing economies. While the superior safety and efficacy of disposable needles are recognized, cost considerations can sometimes lead to a preference for less expensive, albeit riskier, alternatives or a slower adoption rate. Furthermore, stringent regulatory compliances and the lengthy approval processes for new medical devices can pose a considerable challenge for manufacturers. Obtaining necessary certifications and adhering to evolving quality standards from regulatory bodies like the FDA and EMA requires substantial investment in time and resources. The fluctuations in raw material prices, such as stainless steel and plastics, can also impact manufacturing costs and, consequently, market pricing, affecting profitability and potentially slowing down market expansion. Another restraint is the growing adoption of alternative blood collection methods. While not yet widespread, research into less invasive techniques, such as microneedle patches for certain biomarkers, could, in the long term, present a competitive threat to traditional venous blood collection. Additionally, improper disposal practices in some regions can lead to environmental concerns and potential safety hazards, necessitating greater education and infrastructure development for safe medical waste management. The ethical considerations and potential limitations surrounding the disposal of medical waste can also indirectly influence market dynamics.
Key Region or Country & Segment to Dominate the Market
The disposable venous blood collection needle market is characterized by regional dominance and segment-specific demand.
Dominant Segments:
Type: 21G (0.8×27mm)
The 21G needle size is consistently one of the most utilized gauges in routine venipuncture.
Its balance between ease of vein access and minimizing patient discomfort makes it a versatile choice for a wide range of diagnostic tests.
Hospitals and clinics globally rely heavily on this size for routine blood draws, contributing to its significant market share.
Estimated market share for this segment is projected to be around 28% in 2025, growing steadily through the forecast period.
Application: Hospital
Hospitals represent the largest end-user segment for disposable venous blood collection needles.
The sheer volume of patient admissions, surgeries, and diagnostic procedures performed in hospital settings translates into an immense demand for blood collection supplies.
Hospitals are also at the forefront of implementing advanced safety protocols, making disposable needles the standard of care.
This segment is expected to account for over 50% of the total market revenue in 2025 and will likely maintain this dominance.
Dominant Region/Country:
North America
North America, particularly the United States, is projected to be a leading region in the disposable venous blood collection needle market.
This dominance is driven by a high prevalence of chronic diseases, a well-established healthcare infrastructure, and a strong emphasis on patient safety and advanced diagnostic technologies.
The region boasts a significant number of advanced healthcare facilities and a large, aging population that requires regular medical monitoring.
The high disposable income and robust reimbursement policies for medical procedures further bolster market growth in this region.
North America is estimated to hold a market share of approximately 35% in 2025.
Europe
Europe also stands as a significant market, characterized by universal healthcare systems and a high density of healthcare providers.
Countries like Germany, the UK, and France are major contributors due to their extensive healthcare networks and commitment to advanced medical practices.
The focus on infection prevention and control, coupled with a proactive approach to public health, drives the consistent demand for disposable venous blood collection needles.
The European market is expected to capture around 30% of the global market share in 2025.
The synergy between the widespread adoption of the 21G needle size and the extensive utilization within hospital settings, coupled with the mature and safety-conscious healthcare landscape of North America and Europe, solidifies their positions as dominant forces in the disposable venous blood collection needle market. The continuous drive for better patient outcomes and efficient diagnostic processes within these regions will ensure their sustained leadership through the study period.
Growth Catalysts in Disposable Venous Blood Collection Needle Industry
Several factors are acting as significant growth catalysts for the disposable venous blood collection needle industry. The rising global incidence of chronic diseases, such as diabetes and cardiovascular conditions, directly fuels the demand for regular blood testing, making these needles indispensable. Furthermore, an increasing global healthcare expenditure, coupled with expanding healthcare infrastructure in emerging economies, is broadening access to diagnostic services. The unwavering focus on patient safety and infection control protocols worldwide is a paramount catalyst, as disposable needles are essential for preventing cross-contamination and needlestick injuries. Technological advancements in needle design, leading to enhanced patient comfort and reduced procedure time, also contribute to market expansion.
Leading Players in the Disposable Venous Blood Collection Needle
Terumo Corporation
Greiner Bio-One GmbH
Nipro
Roche Diabetes Care GmbH
HTL-Strefa S.A.
Shandong Zhushi Pharmaceutical Group
Hubei Meibang Medical Supplies
Changchun Bethune Medical Equipment
Jiangxi Jinsheng Medical Devices Group
Honghu Taining Medical Appliance
Zhejiang Yusheng Medical Instrument
Jiangsu Kangjian Medical Apparatus
Guangzhou Improve Medical Instruments
Jiangxi Hongda Medical Equipment Group
Shinva Ande Healthcare Apparatus
Shanghai Zhengbang Medical Technology
Jiangsu Kangjie Medical Devices
Jiang Xi Ruibang Industrial Group
Zhejiang Kangkang Medical-Devices
Significant Developments in Disposable Venous Blood Collection Needle Sector
2023: Terumo Corporation launched a new generation of safety-engineered blood collection needles with enhanced user-friendly features and improved patient comfort.
2022: Greiner Bio-One GmbH expanded its manufacturing capacity for disposable blood collection devices to meet the growing demand in emerging markets.
2021: Nipro introduced a novel needle coating technology to reduce venipuncture pain and improve the efficiency of blood collection.
2020: Roche Diabetes Care GmbH focused on integrating its blood collection devices with digital health platforms to facilitate remote patient monitoring.
2019: HTL-Strefa S.A. announced strategic partnerships to enhance its distribution network for disposable venipuncture products in Asia.
This report provides an exhaustive analysis of the disposable venous blood collection needle market, encompassing a detailed examination of market trends, drivers, challenges, and opportunities. It delves into the competitive landscape, profiling key industry players and their strategic initiatives. The report offers robust market forecasts and estimations based on comprehensive data analysis, utilizing a study period from 2019 to 2033, with a base year of 2025 and a forecast period of 2025-2033. It meticulously covers historical data from 2019-2024, providing context for future projections. The report segments the market by needle type (e.g., 20G, 21G, 22G, 23G, 24G) and application (Hospital, Clinic, Industry), alongside regional market analysis, identifying key geographical areas and countries poised for significant growth. This comprehensive approach ensures stakeholders have the insights needed for strategic decision-making.
Table 91: Rest of Asia Pacific Disposable Venous Blood Collection Needle Revenue (million) Forecast, by Application 2020 & 2033
Table 92: Rest of Asia Pacific Disposable Venous Blood Collection Needle Volume (K) Forecast, by Application 2020 & 2033
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders
Secondary Research
Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Disposable Venous Blood Collection Needle?
The projected CAGR is approximately 15.0%.
2. Which companies are prominent players in the Disposable Venous Blood Collection Needle?
Key companies in the market include Terumo Corporation, Greiner Bio-One GmbH, Nipro, Roche Diabetes Care GmbH, HTL-Strefa S.A., Shandong Zhushi Pharmaceutical Group, Hubei Meibang Medical Supplies, Changchun Bethune Medical Equipment, Jiangxi Jinsheng Medical Devices Group, Honghu Taining Medical Appliance, Zhejiang Yusheng Medical Instrument, Jiangsu Kangjian Medical Apparatus, Guangzhou Improve Medical Instruments, Jiangxi Hongda Medical Equipment Group, Shinva Ande Healthcare Apparatus, Shanghai Zhengbang Medical Technology, Jiangsu Kangjie Medical Devices, Jiang Xi Ruibang Industrial Group, Zhejiang Kangkang Medical-Devices, .
3. What are the main segments of the Disposable Venous Blood Collection Needle?
The market segments include Type, Application.
4. Can you provide details about the market size?
The market size is estimated to be USD 245.1 million as of 2022.
5. What are some drivers contributing to market growth?
N/A
6. What are the notable trends driving market growth?
N/A
7. Are there any restraints impacting market growth?
N/A
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3480.00, USD 5220.00, and USD 6960.00 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in million and volume, measured in K.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Disposable Venous Blood Collection Needle," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Disposable Venous Blood Collection Needle report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Disposable Venous Blood Collection Needle?
To stay informed about further developments, trends, and reports in the Disposable Venous Blood Collection Needle, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Disposable Venous Blood Collection Needle